Research and Development

Showing 15 posts of 9573 posts found.

cabometyx_tablets_60_mg_40_mg_20_mg

Ipsen ends P3 trial on liver cancer early due to strong data

January 18, 2018 Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018 Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …
biodegradable_sensor

Fully biodegradable sensor offers safer way to monitor lung and brain conditions

January 17, 2018 Research and Development biodegradable sensor, pharma, university of connecticut

Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in …
celgene_1_02

Celgene rumoured to be revving up for Juno buyout

January 17, 2018 Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Digital solutions from Veeva’s European Commercial & Medical Summit

January 17, 2018 Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, veeva

When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, …
merckwindowweb

MSD’s interim Keytruda combo data spooks Roche and BMS

January 16, 2018 Research and Development MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical

When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
surinder

Hikma bring in new CSO

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …
novartis_outside_1

Novartis debuts new data showing Cosentyx’s superiority over Janssen’s Stelara in psoriasis

January 16, 2018 Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma

Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving …
heartbeat-3077960_960_720

Seizing opportunities in the next steps for real world evidence

January 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …
breast_cancer_awareness

BRCA gene mutation found not to impact survival

January 12, 2018 Medical Communications, Research and Development

The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was …
old_man_bar

Another Alzheimer’s drug bites the dust in P3

January 12, 2018 Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and
barrett_novartis

Novartis prises Pfizer’s Oncology Head away

January 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma

January 11, 2018 Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma

AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …
The Gateway to Local Adoption Series

Latest content